Explore life science companies operating throughout Greater London, from biotechnology startups to global pharmaceutical organisations.
Automated cell culture systems and CDMO for cell therapy manufacturing
Mytos is a biotechnology company developing automated cell culture systems for pharmaceutical and biotechnology customers, replacing manual T-flask culture with closed, robotic instrumentation to improve reproducibility and scalability of human cell production. The platform serves drug discovery and clinical-stage…
UK national centre advancing alternatives to animal research
The NC3Rs is a UK scientific organisation dedicated to the replacement, reduction, and refinement of animals in research and testing. Funded primarily through MRC and BBSRC, it supports the development and adoption of 3Rs approaches across academia, pharma, and regulatory science through grant funding, early career…
Cancer Research UK's translational and commercialisation arm
Cancer Research Horizons is the translational subsidiary of Cancer Research UK, operating at the interface between academic research and industry. The organisation combines in-house drug discovery expertise across six UK sites with technology transfer, licensing, and early-stage venture investment activities. It…
AI-driven AAV capsid engineering for next-generation gene therapy
Lir Therapeutics is an early-stage biotechnology company redesigning adeno-associated virus capsids for gene therapy using an AI-first platform. Its platform integrates high-throughput experimental data generation with machine learning models trained on structural, functional and immunogenicity representations of…
Microbial food-waste treatment integrated with robotic handling
Vuala is an industrial biotechnology and robotics company developing on-site food-waste treatment equipment. Its systems combine microorganisms with automated handling and separation to process mixed food waste into a stabilised organic feedstock suitable for downstream energy recovery. Robotics manage bin lifting,…
Menstrual blood biomarker test for gynaecological condition diagnosis
Woost is a biotechnology company developing a home test kit and AI-assisted digital platform that uses menstrual blood as a diagnostic matrix for gynaecological conditions. The platform enables women to track condition-relevant biomarkers from self-collected samples, with initial focus on polycystic ovary syndrome.…
Biotech-manufactured botanical extracts and bioactive ingredients for industry
YOHOLIFE is a London-based biotechnology company producing botanical extracts and bioactive ingredients through plant cell culture and synthetic biology techniques. The company integrates in-house research, manufacturing and compliance to develop application-ready ingredients for the cosmetic, nutraceutical and…
Cloud R&D platform for life sciences data, workflows, and collaboration
Benchling UK Ltd is the UK subsidiary of Benchling, a cloud-based software platform providing integrated research and development tools for biotechnology and pharmaceutical organisations. The platform covers electronic lab notebooks, molecular sequence design, sample and inventory management, workflow automation,…
Cell-free enzymatic DNA manufacturing for genetic medicines
Touchlight is a contract development and manufacturing organisation producing synthetic DNA for genetic medicine applications using a cell-free enzymatic process. Its linear, covalently closed DNA constructs are free from bacterial sequences and antibiotic resistance genes, offering regulatory and safety advantages…
Early phase clinical trial CRO based at London Bridge
Richmond Pharmacology is a contract research organisation specialising in early phase and first-in-human clinical trials for pharmaceutical and biotech companies. Operating from hospital-adjacent facilities at London Bridge and St George's University London, the company has conducted over 20% of all UK Phase I studies…
Clinical-stage medicines for alcohol use disorder and PTSD
Solvonis Therapeutics is a clinical-stage biopharmaceutical company developing treatments for addiction and mental health disorders. Its lead programme is in Phase III for severe alcohol use disorder, with additional programmes addressing moderate to severe alcohol use disorder, post-traumatic stress disorder and…
Autonomous laboratory infrastructure for AI-ready biological data
Substrate Bio is a London biotechnology company developing AI-native automated laboratory infrastructure for biological data generation. Its platform combines robotic workcells, experimental orchestration software and structured data capture to support reproducible protein science and functional genomics workflows. It…
Distributor of clinical diagnostics and cleanroom solutions
AB Scientific is a UK distributor supplying clinical diagnostics and industrial cleanroom solutions to NHS hospitals, pharmaceutical manufacturers and research laboratories across the UK and Ireland. Its clinical division provides quality control materials, reagents and instrumentation across haematology, clinical…
Synthetic biology facility for gene design, engineering and characterisation
The London Biofoundry is a core facility of SynbiCITE, the UK's national Innovation and Knowledge Centre for Engineering Biology, based at Imperial College London's White City Campus. The facility uses advanced robotic systems to provide design, build, test, and learn services for synthetic DNA and engineered…
Epigenetic reprogramming and senolytic therapeutics for cancer and ageing
199 Biotechnologies is a preclinical-stage biotechnology company developing epigenetic reprogramming and senolytic therapies targeting cancer and age-related disease. Its lead programme applies partial cellular reprogramming to modify the behaviour of glioblastoma cells, reducing malignancy and reactivating natural…
Personalised T cell therapy platform for solid tumour treatment
Swarm Oncology is a pre-clinical biotechnology company developing personalised T cell therapies for advanced solid cancers. Its platform combines in vivo immune priming with proprietary ex vivo cell processing to generate large numbers of potent, non-exhausted T cells with tumour-homing phenotypes, addressing a key…
University core facility for spatial transcriptomics and multi-omics
The Spatial Biology Facility is a university core research facility offering spatial transcriptomics, proteomics and multi-omics services. Using imaging-based platforms, it maps RNA and protein expression at single-cell resolution within intact tissue sections. The facility supports researchers with experimental…
Human iPSC-based safety and genotoxicity testing for gene therapy vectors
TestAVec is a provider of in vitro safety testing services for gene therapy and viral vector products, serving academic researchers and industry developers. The company's human stem cell based platform assesses vector-induced genotoxicity, evaluates patients' DNA repair capacity ahead of radiation or chemotherapy, and…
Specialty pharma delivering niche medicines and novel drug delivery technology
Therakind is a specialty pharmaceutical company focused on developing niche medicines for difficult-to-treat patient populations, including children and the elderly. The company has obtained regulatory approvals for three products across the FDA, EMA and MHRA, and has developed a proprietary intranasal dry powder…
Preclinical cardioprotective proteins for heart attack treatment
Forcefield Therapeutics is a preclinical biotechnology company developing cardioprotective protein therapies for acute myocardial infarction. Its programme uses naturally occurring proteins identified through the FunSel discovery platform to protect cardiomyocytes after a heart attack, reduce tissue damage and…